ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Adolescents and young adults
  • Advocacy
  • Anal cancer
  • Antioxidants
  • AYA
  • Bladder cancer
  • Blood cancers
  • Brain cancer
  • Breast cancer
  • Cancer care delivery
  • Caregiving
  • Chemotherapy
  • Chronic lymphocytic leukemia
  • Colorectal cancer
  • ComboMATCH
  • Communication
  • COVID-19
  • DCIS
  • De-escalation
  • Esophagus cancer
  • Financial hardship
  • Gallbladder cancer
  • Gastroesophageal cancer
  • Geriatric oncology
  • GI cancer
  • Green tea
  • HAI chemotherapy
  • Head and neck cancer
  • Head and neck squamous cell carcinoma
  • Health equity
  • Hepatic arterial infusion chemotherapy.
  • HER2+ breast cancer
  • Hormone therapy
  • Imaging
  • Immune system therapy
  • Immunotherapy
  • Implementation science
  • In memory
  • Kidney cancer
  • Language
  • Late Effects
  • Leiomyosarcoma
  • Leukemia
  • LGBTQ+
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Mantle cell lymphoma
  • Melanoma
  • Men's health
  • Mesothelioma
  • Minimal residual disease
  • MRI
  • Multiple myeloma
  • Myelodysplastic syndrome
  • Myeloma
  • National Clinical Trials Network
  • NCI-MATCH
  • Neuropathy
  • Non-Hodgkin lymphoma
  • Non-small cell lung cancer
  • Nose and sinus cancer
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient advocacy
  • Patient care
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penile cancer
  • Peripheral T-cell lymphoma
  • Personalized medicine
  • Personalized screening
  • Personalized treatment
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Radiation therapy
  • Rare cancer
  • Rare cancers
  • Real-world data
  • Real-world evidence
  • Registry studies
  • Renal cell carcinoma
  • Research results
  • Sarcoma
  • Screening
  • Sexual and gender minorities
  • Side effects
  • Skin cancer
  • Smoldering multiple myeloma
  • Social genomics
  • Soft tissue sarcoma
  • Solid tumors
  • Squamous cell carcinoma
  • Surveillance
  • Survivorship
  • Symptom management
  • Symptom science
  • Targeted therapy
  • Throat cancer
  • Thyroid cancer
  • Trial results
  • Triple-negative breast cancer
  • Tumor test
  • Upper tract urothelial cancer
  • Urothelial cancer
November 3, 2025
November 3, 2025
Categories
  • Editorials

What a difference patients make: Honoring the impact of cancer clinical trial participants

ECOG-ACRIN’s Trial Results Summaries Project aims to inform participants of study findings and express gratitude for their contributions to cancer research
Do you like it?
0 Read more
March 26, 2024
March 26, 2024
Categories
  • Editorials

Improving the publication to practice pipeline: Effective dissemination of research results

Advocates can play an important role in communicating the results of clinical research to their communities
Do you like it?
0 Read more
March 26, 2024
Research dictionary entry
March 26, 2024
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Spring 2024

Summaries of recent publications by researchers affiliated with ECOG-ACRIN
Do you like it?
0 Read more
July 19, 2023
July 19, 2023
Categories
  • Editorials

7 ways advocates have enhanced ECOG-ACRIN’s cancer research program

ECOG-ACRIN’s cancer research advocates recently reflected on their committee’s key accomplishments
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Tags

Acute lymphoblastic leukemia Adolescents and young adults Advocacy Bladder cancer Breast cancer Caregiving Communication De-escalation Head and neck cancer Health equity HER2+ breast cancer Immune system therapy Immunotherapy In memory Kidney cancer Leukemia Lung cancer Lymphoma Mammography Mantle cell lymphoma Melanoma Multiple myeloma Myeloma NCI-MATCH Nose and sinus cancer Pancreatic cancer Pancreatic cysts Patient care Personalized medicine Personalized screening Personalized treatment Precision medicine Prevention Prostate cancer Renal cell carcinoma Research results Sarcoma Screening Side effects Squamous cell carcinoma Surveillance Survivorship Symptom management Targeted therapy Throat cancer

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc